Get started
Author

Giusy Gentilcore

Observed names: G. Gentilcore, Giuseppina Gentilcore
Observed institutions: German Cancer Research Center, Karolinska Institutet, Sidra Medical and Research Center, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Istituto di Chimica Biomolecolare, National Research Council
ORCID: 0000-0003-3546-8642
Observed ORCID: 0000-0003-3546-8642
OpenAlex ID: A5048796106
Paracrine Mechanisms of Mesenchymal Stromal Cells in Angiogenesis
2020 · Selma Maacha, Heba Sidahmed, et al. · Stem Cells International · 269
PDF
Immunological and biological changes during ipilimumab treatment and their potential correlation with clinical response and survival in patients with advanced melanoma
2014 · Ester Simeone, Giusy Gentilcore, et al. · Cancer Immunology Immunotherapy · 257
Main roads to melanoma
2009 · Giuseppe Palmieri, Mariaelena Capone, et al. · Journal of Translational Medicine · 190
PDF
T cells in chronic lymphocytic leukemia display dysregulated expression of immune checkpoints and activation markers
2016 · Marzia Palma, Giusy Gentilcore, et al. · Haematologica · 168
PDF
NF-κB as potential target in the treatment of melanoma
2012 · Gabriele Madonna, Claudio Dansky Ullman, et al. · Journal of Translational Medicine · 144
PDF
Ipilimumab Treatment Results in an Early Decrease in the Frequency of Circulating Granulocytic Myeloid-Derived Suppressor Cells as well as Their Arginase1 Production
2013 · Yago Pico de Coaña, Isabel Poschke, et al. · Cancer Immunology Research · 141
PDF
Laminins 411 and 421 differentially promote tumor cell migration via α6β1 integrin and MCAM (CD146)
2014 · Taichi Ishikawa, Zenebech Wondimu, et al. · Matrix Biology · 89
PDF
Assessing a novel immuno-oncology-based combination therapy: Ipilimumab plus electrochemotherapy
2015 · Nicola Mozzillo, Ester Simeone, et al. · OncoImmunology · 84
Revving up Natural Killer Cells and Cytokine-Induced Killer Cells Against Hematological Malignancies
2015 · Gianfranco Pittari, Perla Filippini, et al. · Frontiers in Immunology · 75
PDF
Low-dose temozolomide before dendritic-cell vaccination reduces (specifically) CD4+CD25++Foxp3+ regulatory T-cells in advanced melanoma patients
2013 · Laura Ridolfi, Massimiliano Petrini, et al. · Journal of Translational Medicine · 71
PDF
Association of CTLA-4 Polymorphisms with Improved Overall Survival in Melanoma Patients Treated with CTLA-4 Blockade: A Pilot Study
2013 · P. Queirolo, A. Morabito, et al. · Cancer Investigation · 58
Effect of dabrafenib on melanoma cell lines harbouring the BRAF V600D/R mutations
2013 · Giusy Gentilcore, Gabriele Madonna, et al. · BMC Cancer · 50
PDF
Regulatory T cell frequency in patients with melanoma with different disease stage and course, and modulating effects of high-dose interferon-α 2b treatment
2010 · Paolo A Ascierto, Maria Napolitano, et al. · Journal of Translational Medicine · 46
PDF
Increased HOX C13 expression in metastatic melanoma progression
2012 · Monica Cantile, Giosuè Scognamiglio, et al. · Journal of Translational Medicine · 43
PDF
High–temporal resolution profiling reveals distinct immune trajectories following the first and second doses of COVID-19 mRNA vaccines
2022 · Darawan Rinchai, Sara Deola, et al. · Science Advances · 38
PDF
NEMO-binding domain peptide inhibits proliferation of human melanoma cells
2008 · Angela Ianaro, Mariaroberta Tersigni, et al. · Cancer Letters · 33
Effect of ABT-888 on the apoptosis, motility and invasiveness of BRAFi-resistant melanoma cells
2018 · Federica Fratangelo, Rosa Camerlingo, et al. · International Journal of Oncology · 26
PDF
Melanoma and immunotherapy bridge 2015
2016 · Vashisht G. Y. Nanda, Weiyi Peng, et al. · Journal of Translational Medicine · 22
PDF
Antibody‐dependent enhancement (ADE) of SARS‐CoV‐2 in patients exposed to MERS‐CoV and SARS‐CoV‐2 antigens
2024 · Swapna Thomas, Maria K. Smatti, et al. · Journal of Medical Virology · 15
PDF
Lenalidomide as immune adjuvant to a dendritic cell vaccine in chronic lymphocytic leukemia patients
2018 · Marzia Palma, Lotta Hansson, et al. · European Journal Of Haematology · 15
Immunological and biological changes during ipilimumab (Ipi) treatment and their correlation with clinical response and survival.
2012 · Ester Simeone, Giusy Gentilcore, et al. · Journal of Clinical Oncology · 13
Ipilimumab treatment results in an early decrease in the frequency of circulating granulocytic myeloid derived suppressor cells as well as their arginase1 production
2014 · Giusy Gentilcore, Coaña Pico de Yago, et al. · Journal of Translational Medicine · 12
PDF
Distinctive blood and salivary proteomics signatures in Qatari individuals at high risk for cardiovascular disease
2025 · Ghada Yousif, Selvasankar Murugesan, et al. · Scientific Reports · 9
PDF
Microbial and proteomic signatures of type 2 diabetes in an Arab population
2024 · Selvasankar Murugesan, Ghada Yousif, et al. · Journal of Translational Medicine · 9
PDF
Immunoglobulin-coating patterns reveal altered humoral responses to gut bacteria in pediatric cow milk allergies
2024 · Tracy Augustine, Selvasankar Murugesan, et al. · Journal of Translational Medicine · 8
Works count: 59
Citation count: 1,927
H-index: 18
I10-index: 22
Year
Topic
Type